|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2022
12 months to Mar 31, 2023
|
FY2021
12 months to Mar 31, 2022
|
|
|---|---|---|---|---|
| Cash flows from operating activities: | ||||
| Net loss | ||||
| Investment income earned on investments held in Trust Account | ||||
| Adjustments to reconcile net loss to net cash used in operating activities: | ||||
| Depreciation and amortization | ||||
| Amortization of convertible notes discount | ||||
| Amortization of right-of-use asset | ||||
| Change in fair value of derivative liability | ||||
| Bad debt expense | ||||
| Change in OCI | ||||
| Loss on extinguishment of debt | ||||
| Stock issued for make good provisions on debt conversion | ||||
| Stock options issued to employees | ||||
| Stock issued for services | ||||
| Changes in operating assets and liabilities: | ||||
| Accounts receivable, net | ||||
| Inventory, net | ||||
| Prepaid expenses | ||||
| Accrued expenses | ||||
| Accrued expenses - related parties | ||||
| Taxes payable | ||||
| Other current assets | ||||
| Other assets | ||||
| Accounts payable | ||||
| Deferred revenue | ||||
| Accrued interest payable | ||||
| Accrued and other current liabilities | ||||
| Other liabilities | ||||
| Lease liability | ||||
| Net cash used in operating activities | ||||
| Cash flows from investing activities: | ||||
| Distribution for taxes payments | ||||
| Cash released from trust account | ||||
| Investment of cash in Trust Account | ||||
| Purchases of property and equipment | ||||
| Capitalized software, net | ||||
| Sale of short-term investments | ||||
| Net cash provided by (used in) investing activities | ||||
| Cash flows from financing activities: | ||||
| Proceeds from PIPE loans, net of discount | ||||
| Proceeds from exercise of Series A Preferred warrants | ||||
| Proceeds from notes payable - related party | ||||
| Cash used for common stock redemption | ||||
| Cash and cash equivalents at the beginning of the period | ||||
| Cash and cash equivalents at the end of the period | ||||
| Proceeds from investment fund (PIPE) | ||||
| Cash acquired in Merger | ||||
| Debt refinance conversion | ||||
| Costs of Merger paid from PIPE loan | ||||
| Repayments of line of credit | ||||
| Repayments of loans assumed in Merger | ||||
| Repayments of liabilities assumed in Merger | ||||
| Repayments of notes payable | ||||
| Repayments of notes payable - related party | ||||
| Net cash provided by financing activities | ||||
| Net change in cash, cash equivalents and restricted cash | ||||
| Cash, cash equivalents and restricted cash - beginning of year | ||||
| Cash, cash equivalents and restricted cash - end of year | ||||
| Supplemental cash flow information: | ||||
| Interest | ||||
| Reclassification of Class A common stock | ||||
| Remeasurement for Class A common stock subject to possible redemption | ||||
| Non-cash investing and financing activities: | ||||
| PIPE note principal converted to Class A Common Stock | ||||
| Dividend note principal converted to Class A and Class B Common Stock | ||||
| Exchange of PIPE Notes and Series A and B Warrants for Series A Convertible Preferred Stock and Warrants for Series A Convertible Preferred Stock | ||||
| Series A Convertible Preferred Stock issued in exchange of PIPE Notes | ||||
| Series A Convertible Preferred Stock dividends converted to Class A Common Stock | ||||
| Right-of-use assets obtained in exchange for operating lease liabilities (lease modification) | ||||
| Convertible notes exchanged for PIPE note | ||||
| Class A Common Stock exchanged in Merger | ||||
| Class A Common Stock issued in Merger | ||||
| Class B Common Stock issued in Merger | ||||
| Derivative liability related to warrants | ||||
| Termination of loan payable | ||||
Loading...